TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
active
Official procurement procedure

(NU/1850) The Provision of Metabolomic Analysis Services (AbsolutelDQ Bile Acids kit and MxP Quant 500 Kits) for the NASH-DTA Retrospective and Prospective Study

Research laboratory services
Research services
North East (UKC22)
Published value
£388,000
Submission deadline 13 Feb 2023, 12:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Newcastle University: "(NU/1850) The Provision of Metabolomic Analysis Services (AbsolutelDQ Bile Acids kit and MxP Quant 500 Kits) for the NASH-DTA Retrospective and Prospective Study". Published status: active. Published value: £388,000. 1 published lot. Recorded submission deadline: 13 Feb 2023, 12:00 GMT. See the official notice for participation instructions.
Contracting AuthorityNewcastle UniversityScope & CategoriesNot publishedSubmission Window
Closed
13 Feb 2023, 12:00 GMT
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£388,000
Bidder Intelligence · Authority Profile: Newcastle University
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Newcastle University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.4Bids / Report
38.8% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 104 active published awards; 98 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNewcastle University
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Jan 2023, 10:34 GMT
Last source update11 Jan 2023, 10:34 GMT
Recurring procurementNo
ClassificationResearch laboratory services, Research services
Delivery area
North East (UKC22)
OCIDocds-h6vhtk-039679
What is being bought
The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the “NASH Disease Translational Accelerator” (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The NASH-DTA project has two parts: retrospective and prospective study. Retrospective study is based on analysing existing samples, prospective study will recruit 200 patients and collect new samples over 5 years. The purpose of this tender process is to engage a supplier to provide metabolomic analysis on plasma samples from both a retrospective and prospective study using AbsolutelDQ Bile Acids kit and MxP Quant 500 Kit.
What changed
From the official release history
  1. Published value updated to £388,000
    11 Jan 2023, 10:34 GMT
  2. Status changed to active
    11 Jan 2023, 10:34 GMT
  3. Official notice release published
    11 Jan 2023, 10:34 GMT
  4. Submission deadline changed to 13 Feb 2023, 12:00 GMT
    11 Jan 2023, 10:34 GMT
  5. Buyer information updated
    11 Jan 2023, 10:34 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    active
    Published valueNot published
    The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the “NASH Disease Translational Accelerator” (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The NASH-DTA project has two parts: retrospective and prospective study. Retrospective study is based on analysing existing samples, prospective study will recruit 200 patients and collect new samples over 5 years. The purpose of this tender process is to engage a supplier to provide metabolomic analysis on plasma samples from both a retrospective and prospective study using AbsolutelDQ Bile Acids kit and MxP Quant 500 Kit.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Jan 2023, 10:34 GMT
  2. Submission deadline
    13 Feb 2023, 12:00 GMT
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Newcastle University

Contracting authority GB-FTS-168
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published